Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

NCT06491446 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
141
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Antiva Biosciences